NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients

Autor: Kuroda, Junya, Kodama, Ayumi, Chinen, Yoshiaki, Shimura, Yuji, Mizutani, Shinsuke, Nagoshi, Hisao, Kobayashi, Tsutomu, Matsumoto, Yosuke, Nakaya, Yohei, Tamura, Ayako, Kobayashi, Yutaka, Naito, Haruna, Taniwaki, Masafumi
Zdroj: In Leukemia Research May 2014 38(5):619-624
Databáze: ScienceDirect